Literature DB >> 6219689

Treatment of rosacea with i% metronidazole cream. A double-blind study.

P G Nielsen.   

Abstract

Eighty-one patients with rosacea were treated with either I% metronidazole cream or the cream base as a placebo for two months. The trial was performed double-blind, and the patients were assessed once each month. The variates studied were: (I) overall clinical assessment, (2) lesion counts, (3) degree of erythema, (4) independent photographic evaluation, and (5) patient's opinion. Four patients dropped out of the trial (one treated with metronidazole, three with placebo). In all the variates, I% metronidazole cream proved to be significantly more effective than placebo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6219689     DOI: 10.1111/j.1365-2133.1983.tb03972.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

1.  Impact of topical metronidazole on the skin and colon microflora in patients with rosacea.

Authors:  G Eriksson; C E Nord
Journal:  Infection       Date:  1987 Jan-Feb       Impact factor: 3.553

Review 2.  [Rosacea. Clinical features, pathogenesis and therapy].

Authors:  P Lehmann
Journal:  Hautarzt       Date:  2005-09       Impact factor: 0.751

3.  Topical treatments for rosacea.

Authors:  Paul Fritsch; Michael R Kolber; Christina Korownyk
Journal:  Can Fam Physician       Date:  2019-11       Impact factor: 3.275

Review 4.  Interventions for rosacea.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Ben Carter; Mireille M D van der Linden; Lyn Charland
Journal:  Cochrane Database Syst Rev       Date:  2015-04-28

Review 5.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

6.  Placebo controlled trial of fusidic acid gel and oxytetracycline for recurrent blepharitis and rosacea.

Authors:  D V Seal; P Wright; L Ficker; K Hagan; M Troski; P Menday
Journal:  Br J Ophthalmol       Date:  1995-01       Impact factor: 4.638

7.  Metronidazole gel (0.75%) in Japanese patients with rosacea: A randomized, vehicle-controlled, phase 3 study.

Authors:  Yoshiki Miyachi; Kenshi Yamasaki; Tomomitsu Fujita; Chie Fujii
Journal:  J Dermatol       Date:  2021-12-01       Impact factor: 3.468

Review 8.  Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments.

Authors:  E J van Zuuren; Z Fedorowicz; J Tan; M M D van der Linden; B W M Arents; B Carter; L Charland
Journal:  Br J Dermatol       Date:  2019-03-10       Impact factor: 9.302

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.